About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5906203
Allelic
Composition
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Ckmm-cre)5Khn/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Gsf mutation (0 available); any Ptpn11 mutation (43 available)
Tg(Ckmm-cre)5Khn mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• 66% increase in heart/body weight ratios

mortality/aging
• mice begin to die within 2 weeks after birth and have a median survival age of 13.4 weeks, with very few living up to 36 weeks

cardiovascular system
• elevation in levels of triglyceride in the heart
• however, no differences in glycogen content of cardiac muscle
• cardiomyocyte capacitance, a measure of cell size, is augmented, with cells showing a 2-fold increase in capacitance
• 66% increase in heart/body weight ratios
• enlarged right and left ventricle chambers with thinner walls
• however, fibrosis, changes in apoptosis or proliferation,or lymphocyte and macrophage infiltration in the heart are not seen
• glucose uptake is impaired in cardiac muscle cells
• decrease in left ventricular fraction shortening and the velocity of circumferential fiber shortening
• enlarged left ventricular chamber size in 6 week old mice, increase in left ventricular internal dimension at end diastole and end systole, and significant wall thinning as evidenced by decrease in systolic dimensions in interventricular septal wall thickness
• however, no change in left ventricular posterior wall thickness is seen
• cardiomyocytes exhibit slower calcium current density (inward current amplitude normalized to cell capacitance)

cellular
• glucose uptake is impaired in skeletal muscle cells
• glucose uptake is impaired in cardiac muscle cells

homeostasis/metabolism
• elevation in levels of triglyceride in the heart
• however, no differences in glycogen content of cardiac muscle
• circulating insulin levels under fed and fasted conditions are slightly increased
• elevation in levels of triglyceride in plasma
• however, no differences in circulating free fatty acids
• glucose intolerance, with the most significant difference seen at 120 min after glucose injection
• males and females show a decreased ability to lower circulating glucose levels after intraperitoneal injection of insulin
• elevation in levels of triglyceride in skeletal muscle
• however, no differences in glycogen content of skeletal muscle

muscle
• elevation in levels of triglyceride in the heart
• however, no differences in glycogen content of cardiac muscle
• cardiomyocyte capacitance, a measure of cell size, is augmented, with cells showing a 2-fold increase in capacitance
• enlarged right and left ventricle chambers with thinner walls
• however, fibrosis, changes in apoptosis or proliferation,or lymphocyte and macrophage infiltration in the heart are not seen
• decrease in left ventricular fraction shortening and the velocity of circumferential fiber shortening
• glucose uptake is impaired in skeletal muscle cells
• glucose uptake is impaired in cardiac muscle cells
• elevation in levels of triglyceride in skeletal muscle
• however, no differences in glycogen content of skeletal muscle


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory